Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.878 | 49 | 2001 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.878 | 49 | 2001 | 2019 | ||||
Malignant neoplasm of stomach
|
615 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.750 | 16 | 2002 | 2018 | ||||
Stomach Carcinoma
|
652 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.750 | 16 | 2002 | 2018 | ||||
Skin carcinoma
|
24 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.030 | 1.000 | 3 | 2002 | 2017 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.030 | 0.333 | 3 | 2002 | 2009 | ||||
Adenocarcinoma of pancreas
|
138 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||
Carcinoma of lung
|
1204 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.813 | 16 | 2003 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.800 | 15 | 2003 | 2017 | ||||
Laryngeal Squamous Cell Carcinoma
|
30 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.020 | 1.000 | 2 | 2003 | 2013 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.960 | 25 | 2004 | 2017 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.960 | 25 | 2004 | 2016 | ||||
Colorectal Carcinoma
|
1962 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.833 | 24 | 2004 | 2016 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.867 | 15 | 2004 | 2015 | ||||
Carcinoma of bladder
|
309 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.615 | 13 | 2004 | 2016 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.615 | 13 | 2004 | 2016 | ||||
Bladder Neoplasm
|
281 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.583 | 12 | 2004 | 2016 | ||||
Malignant neoplasm of prostate
|
1082 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.900 | 10 | 2004 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.900 | 10 | 2004 | 2018 | ||||
Congenital chromosomal disease
|
47 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.060 | 1.000 | 6 | 2004 | 2012 | ||||
Esophageal carcinoma
|
272 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.040 | 0.750 | 4 | 2004 | 2013 | ||||
Esophageal Neoplasms
|
270 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.040 | 0.750 | 4 | 2004 | 2013 |